14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 FATE stock ended at $4.22. This is 3.94% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 6.23% from a day low at $4.01 to a day high of $4.26.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Nov 08, 2021 $61.13 $63.02 $60.57 $60.79 611 701
Nov 05, 2021 $59.36 $63.28 $57.63 $61.42 964 513
Nov 04, 2021 $60.43 $60.51 $57.95 $59.65 1 346 084
Nov 03, 2021 $57.63 $60.50 $57.21 $60.38 635 005
Nov 02, 2021 $57.92 $58.07 $56.06 $57.86 537 077
Nov 01, 2021 $53.79 $58.33 $52.42 $57.76 867 253
Oct 29, 2021 $56.20 $56.20 $53.75 $53.80 718 970
Oct 28, 2021 $55.27 $56.72 $54.24 $55.98 773 124
Oct 27, 2021 $59.05 $60.10 $54.83 $54.84 1 238 346
Oct 26, 2021 $58.31 $60.60 $57.50 $59.31 2 400 869
Oct 25, 2021 $58.91 $59.77 $57.17 $58.16 1 368 503
Oct 22, 2021 $59.40 $59.50 $58.10 $59.00 689 408
Oct 21, 2021 $60.16 $61.26 $59.01 $59.48 790 245
Oct 20, 2021 $60.89 $61.91 $59.41 $59.57 638 214
Oct 19, 2021 $60.63 $63.23 $60.12 $61.17 1 340 388
Oct 18, 2021 $60.71 $61.61 $59.79 $60.11 590 862
Oct 15, 2021 $63.62 $63.72 $60.97 $61.24 807 868
Oct 14, 2021 $61.00 $63.37 $60.79 $62.51 697 171
Oct 13, 2021 $59.34 $60.60 $58.69 $60.15 901 165
Oct 12, 2021 $57.11 $59.25 $56.84 $59.07 837 166
Oct 11, 2021 $54.93 $56.99 $54.49 $56.55 720 912
Oct 08, 2021 $56.94 $58.32 $54.57 $54.93 861 056
Oct 07, 2021 $57.51 $58.97 $56.18 $56.33 795 571
Oct 06, 2021 $56.37 $57.64 $54.88 $57.12 874 117
Oct 05, 2021 $57.01 $57.54 $55.06 $57.30 953 788
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT